ClinicalTrials.gov
public full text
Public Domain
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
The primary purpose is to study the efficacy, safety, and tolerability of LY2216684 as an adjunctive treatment for participants with major depressive disorder (MDD), who were identified as partial responders to an adequate course of treatment with a selective serotonin reuptake inhibitor (SSRI) (as defined by history).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Signature Response to Light Therapy in Unipolar and Bipolar Major Depressive Episode (MDE)#864050
- Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder#1060626
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder#1058862
- D-cycloserine for Major Depressive Disorder#812425
- Bipolar II Depression: Lithium, SSRI, or the Combination#851370
Record · ID 1093811
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive